Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000039265Phase 4Recruiting
Phase 4, open-label trial of propofol, midazolam and nalbuphine in None (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Rate of vasopressor use. Started Nov 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000039265.